1. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
- Author
-
Dbouk M, Brewer Gutierrez OI, Lennon AM, Chuidian M, Shin EJ, Kamel IR, Fishman EK, He J, Burkhart RA, Wolfgang CL, Hruban RH, Goggins MG, and Canto MI
- Subjects
- Adult, Aged, Carcinoma in Situ surgery, Consensus Development Conferences as Topic, Early Detection of Cancer methods, Female, Follow-Up Studies, Humans, Male, Middle Aged, Pancreatic Cyst diagnosis, Pancreatic Intraductal Neoplasms surgery, Pancreatic Neoplasms surgery, Practice Guidelines as Topic, Retrospective Studies, Risk, Sensitivity and Specificity, Carcinoma in Situ diagnosis, Early Detection of Cancer standards, Pancreatic Cyst surgery, Pancreatic Intraductal Neoplasms diagnosis, Pancreatic Neoplasms diagnosis
- Abstract
Background: Objectives: Pancreatic cysts are frequently detected in high-risk individuals (HRI) undergoing surveillance for pancreatic cancer. The International Cancer of the Pancreas Screening (CAPS) Consortium developed consensus recommendations for surgical resection of pancreatic cysts in HRI that are similar to the Fukuoka guidelines used for the management of sporadic cysts. We compared the performance characteristics of CAPS criteria for pancreatic cyst management in HRI with the Fukuoka guidelines originally designed for the management of cysts in non-HRI., Methods: Using prospectively collected data from CAPS studies, we determined for each patient with resected screen-detected cyst(s) whether Fukuoka guidelines or CAPS consensus statements would have recommended surgery. We compared sensitivity, specificity, PPV, NPV, and Receiver Operator Characteristics (ROC) curves of these guidelines at predicting the presence of high-grade dysplasia or invasive cancer in pancreatic cysts., Results: 356/732 HRI had ≥ one pancreatic cyst detected; 24 had surgery for concerning cystic lesions. The sensitivity, specificity, PPV, and NPV for the Fukuoka criteria were 40%, 85%, 40%, and 85%, while those of the CAPS criteria were 60%, 85%, 50%, 89%, respectively. ROC curve analyses showed no significant difference between the Fukuoka and CAPS criteria., Conclusions: In HRI, the CAPS and Fukuoka criteria are moderately specific, but not sufficiently sensitive for detecting advanced neoplasia in cystic lesions. New approaches are needed to guide the surgical management of cystic lesions in HRI., Competing Interests: Declaration of competing interest Dr. Hruban has the right to receive royalty payments from Thrive Earlier Detection for the GNAS invention through a relationship managed by Johns Hopkins University. All other authors disclose no conflicts of interest., (Copyright © 2021. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF